PharmiNews

Directory of Pharma Companies and News

Company Profile

AVEO Pharmaceuticals, inc

AVEO Pharmaceuticals, inc logo
Category
AVEO PHARMACEUTICALS, INC is a biopharmaceutical company that is focused on developing and commercialising its lead candidate tivozanib, a potent, selective, long half-life inhibitor of vascular endothelial growth factor, 1, 2 and 3 receptors, in North America as a treatment for renal cell carcinoma. AVEO is leveraging multiple partnerships to develop and commercialise tivozanib in non-oncologic indications worldwide and oncology indications outside of North America.
Keywords:
0 results
Brought to you by PharmiWeb.com - Latest Jobs in Pharma